Antibody that specifically binds to Candida kefyr Cytosine deaminase
US7414113B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2006 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Sep 12, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new cytosine deaminase gene and protein from Candida kefyr are provided. This protein has increased ability to convert the 5-fluorocytosine prodrug to its toxic form when compared against the E. coli enzyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.